Brd9 | bromodomain containing 9
GeneMGI:2145317
Physiological systems
21 / 24 physiological systems tested
10 Significantly impacted by the knock-out
Homeostasis/metabolism Reproductive system Immune system Endocrine/exocrine gland Integument Growth/size/body region Hematopoietic system Skeleton Mortality/aging Renal/urinary system
11 No significant impact
3 Not tested
Data collections
Gene metrics:9Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
abnormal skin morphology | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Early adult | N/A * | ||
abnormal seminal vesicle morphology | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Late adult | N/A * | ||
preweaning lethality, complete penetrance | 3 supporting datasets | Brd9em1(IMPC)Tcp | homozygote | Early adult | N/A * | ||
small adrenal glands | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Late adult | N/A * | ||
enlarged urinary bladder | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Late adult | N/A * | ||
decreased bone mineral content | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Late adult | 4.85x10-5 | ||
increased circulating HDL cholesterol level | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Early adult | 9.53x10-5 | ||
small uterus | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Late adult | N/A * | ||
increased neutrophil cell number | 1 supporting dataset | Brd9em1(IMPC)Tcp | heterozygote | Early adult | 2.87x10-7 |
| | | | | | | | | |
External links
No external links available for Brd9.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Brd9em1(IMPC)Tcp | Exon Deletion | | mouse |
Brd9tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Brd9tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |